z-logo
open-access-imgOpen Access
Risk stratification of colorectal polyps for predicting residual or recurring adenoma using the Size/Morphology/Site/Access score
Author(s) -
Barosa Rita,
Mohammed Noor,
Rembacken Bjorn
Publication year - 2018
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640617742485
Subject(s) - medicine , risk stratification , adenoma , colorectal cancer , colorectal adenoma , colorectal polyp , stratification (seeds) , residual , general surgery , colonoscopy , cancer , seed dormancy , botany , germination , algorithm , dormancy , computer science , biology
Background and Aims Endoscopic mucosal resection is an effective and safe procedure to manage large non‐pedunculated colonic polyps for which residual/recurrent adenoma is the main drawback. Size/Morphology/Site/Access score determines polypectomy difficulty. We aimed to describe residual/recurrent adenoma rate according to Size/Morphology/Site/Access and to select the ize/Morphology/Site/Access cut‐off to predict low residual/recurrent adenoma. Methods This was a retrospective cohort study of endoscopic mucosal resection for large non‐pedunculated colonic polyps performed in a tertiary centre. Results Three hundred and sixteen procedures were included. The mean size of lesions was 34.5 ± 17.1 mm, 59.5% were sessile, 60.4% were in the right colon and in 17.7% ( n  = 56) the access was difficult. Of the lesions, 83.6% were Size/Morphology/Site/Access 3–4. Residual/recurrent adenoma at first and second follow‐up was significantly lower in Size/Morphology/Site/Access 2 (1.9% and 0.0%, respectively) when compared to Size/Morphology/Site/Access 3 (18.2%, p  = 0.004 and 6.7%, p  = 0.049) and Size/Morphology/Site/Access 4 (30.8%, p  < 0.001 and 22.7%, p  = 0.030). The negative predictive value of Size/Morphology/Site/Access 2 for residual/recurrent adenoma at second follow‐up was 86.1%. On multivariate analyses, Size/Morphology/Site/Access 3–4 predicted residual/recurrent adenoma at first (odds ratio 11.96, 95% confidence interval 1.57–91.13) and second follow‐up (odds ratio 2.47, 95% confidence interval 1.51–4.22) and had higher cumulative incidence of residual/recurrent adenoma compared to Size/Morphology/Site/Access 2 ( p  ≤ 0.003). Conclusion Use of the Size/Morphology/Site/Access score allows cases to be identified with a low risk of residual/recurrent adenoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom